Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
2002 2
2005 1
2006 1
2007 1
2008 2
2009 5
2010 1
2011 1
2012 2
2013 2
2014 1
2015 1
2017 1
2018 1
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Resolving mechanisms of immune-mediated disease in primary CD4 T cells.
Bourges C, Groff AF, Burren OS, Gerhardinger C, Mattioli K, Hutchinson A, Hu T, Anand T, Epping MW, Wallace C, Smith KG, Rinn JL, Lee JC. Bourges C, et al. Among authors: epping mw. EMBO Mol Med. 2020 May 8;12(5):e12112. doi: 10.15252/emmm.202012112. Epub 2020 Apr 1. EMBO Mol Med. 2020. PMID: 32239644 Free PMC article.
FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia.
Manoli I, Sysol JR, Epping MW, Li L, Wang C, Sloan JL, Pass A, Gagné J, Ktena YP, Li L, Trivedi NS, Ouattara B, Zerfas PM, Hoffmann V, Abu-Asab M, Tsokos MG, Kleiner DE, Garone C, Cusmano-Ozog K, Enns GM, Vernon HJ, Andersson HC, Grunewald S, Elkahloun AG, Girard CL, Schnermann J, DiMauro S, Andres-Mateos E, Vandenberghe LH, Chandler RJ, Venditti CP. Manoli I, et al. Among authors: epping mw. JCI Insight. 2018 Dec 6;3(23):e124351. doi: 10.1172/jci.insight.124351. JCI Insight. 2018. PMID: 30518688 Free PMC article.
Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC, Lis R, Patnaik A, Cantley LC, Bubley G, Cordon-Cardo C, Gerald WL, Montironi R, Signoretti S, Loda M, Nardella C, Pandolfi PP. Lunardi A, et al. Among authors: epping mt. Nat Genet. 2020 Oct;52(10):1132. doi: 10.1038/s41588-020-0701-7. Nat Genet. 2020. PMID: 32884149
Apoptosis: target of cancer therapy.
Ferreira CG, Epping M, Kruyt FA, Giaccone G. Ferreira CG, et al. Among authors: epping m. Clin Cancer Res. 2002 Jul;8(7):2024-34. Clin Cancer Res. 2002. PMID: 12114400 Free article. Review.
Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.
González-Billalabeitia E, Seitzer N, Song SJ, Song MS, Patnaik A, Liu XS, Epping MT, Papa A, Hobbs RM, Chen M, Lunardi A, Ng C, Webster KA, Signoretti S, Loda M, Asara JM, Nardella C, Clohessy JG, Cantley LC, Pandolfi PP. González-Billalabeitia E, et al. Among authors: epping mt. Cancer Discov. 2014 Aug;4(8):896-904. doi: 10.1158/2159-8290.CD-13-0230. Epub 2014 May 27. Cancer Discov. 2014. PMID: 24866151 Free PMC article.
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page